Shah Smital
Insider CIK 1808821 · PLRX Director · LYEL Chief Fin. and Bus. Officer · GRPH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2026-03-09 | 2026-03-16 | 140,000 | — | $0 | 140,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| GRPH Graphite Bio, Inc. | A Award deriv | 2023-07-19 | 2023-07-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| GRPH Graphite Bio, Inc. | A Award deriv | 2022-06-21 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2022-06-16 | 2022-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-06-29 | 2021-07-01 | 5,882 | $17.00 | $100.0K | 5,882 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| GRPH Graphite Bio, Inc. | A Award deriv | 2021-04-15 | 2021-07-01 | 93,585 | — | $0 | 93,585 | SEC↗ |